Position in IRD
as of Mar 31, 2026
· filed May 4, 2026
Position Value
$68,250
+$38,100 QoQ
Shares Held
15,000
0.0% QoQ
Ownership
0.018%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2022
15 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in IRD Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Bedel Financial Consulting, Inc. holds $69,200 across 1 Biotechnology name.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RLMD |
Relmada Therapeutics, Inc.
|
10,000 | $69,200 |
All Filings in IRD
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $68,250 | 15,000 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $30,150 | 15,000 | Shares | Sole | 2026-01-28 | |
| 2025-09-30 | $24,750 | 15,000 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $14,100 | 15,000 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $14,700 | 15,000 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $17,850 | 15,000 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $19,650 | 15,000 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $22,950 | 15,000 | Shares | Sole | 2024-08-05 | |
| 2024-03-31 | $30,150 | 15,000 | Shares | Sole | 2024-05-07 | |
| 2023-12-31 | $45,150 | 15,000 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $50,250 | 15,000 | Shares | Sole | 2024-02-08 | |
| 2023-06-30 | $65,100 | 15,000 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $56,250 | 15,000 | Shares | Sole | 2023-05-02 | |
| 2022-12-31 | $52,950 | 15,000 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $30,150 | 15,000 | Shares | Sole | 2022-11-08 | |
| No filing history on record for this holder in this stock. | ||||||